Dalteparin Sodium Market Analysis, Size, Current Scenario and Future Prospects

Dalteparin Sodium Market is estimated to grow at a CAGR of XX% during the forecast period. Dalteparin is a drug that is used to treat and prevent dangerous blood clots. Preventing dangerous blood clots can help you avoid a stroke or heart attack. Dalteparin helps in the smooth flow of blood, by reducing the activity of clotting proteins in the blood. It is commonly known as blood thinner which is  heparin derivative that act as a coagulant. Procedures such as hip replacement or abdominal surgery, long periods of immobility, cert5ain types of heart attacks and type of chest pain, or unstable angina are all raising the chance of dev eloping blood clotsAlthough the kidneys remove heparins, investigations have shown that dalteparin does not accumulate even when renal function is decreased. According to animal studies, over 70% of dalteparin is eliminated through the kidneys.

The global market for dalteparin sodium is expanding, due to the rising prevalence of chronic disorders. Stringent regulations, as well as a scarcity of trained staff with solid technical knowledge, are expected to limit market growth over the projection period. Furthermore, the market for dalteparin sodium is expected to grow due to an increase in government initiatives to improve health-care facilities, a focus on research, and increased research funding

For Instance, In May 2019, approved dalteparin sodium (Fragmin; Pfizer) as the first anticoagulant was approved by the US Fod and drug administration for use in paediatric patients older than one month to prevent symptomatic venous thromboembolism (VTE) caused by illnesses such congenital heart disease and cancer.

To Request a Sample of our Report on Dalteparin Sodium Market :  https://www.omrglobal.com/request-sample/dalteparin-sodium-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segments Covered

By Type
By Application

Regions Covered

North America
Europe
Asia-Pacific
Rest of the world

Competitive Landscape: Shenzhen Hepalink, Nanjing King-friend, Pfizer, SPL, Dongcheng Biochemicals among others.

Dalteparin Sodium Market by Segments,

By Type,

2.5mEq/L
3.5mEq/L
Others

By Application,

Hospital
Medical Centre

A full Report of Dalteparin Sodium Market is Available at:  https://www.omrglobal.com/industry-reports/dalteparin-sodium-market

 Dalteparin Sodium Market by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan 
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/dalteparin-sodium-market

 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.